CD274 and neoplasm: Most current studies on the determinants of clinical responses to ICIs have focused on tumor intrinsic factors, e.g., tumoral PD-L1 expression or oncogenic mutational load [35, 36] instead of characteristics of tumor-infiltrating T cells.